Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas

Daisuke Matsubara1,2, Taichiro Yoshimoto1, Manabu Soda3

  • 1Division of Integrative Pathology, Jichi Medical University, Shimotsuke, Japan.

Cancer Science
|April 3, 2020
PubMed

Insights

Trefoil factor-1 (TFF-1) is highly expressed in non-terminal respiratory unit (non-TRU) lung adenocarcinomas, correlating with KRAS mutations and poor prognosis. TFF-1 shows potential as a biomarker and therapeutic target for these lung cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Targeted therapies for EGFR and ALK mutations have benefited lung adenocarcinoma patients.
  • Targetable mutations are primarily found in TTF-1/NKX2-1-positive terminal respiratory unit (TRU) types, not non-TRU types.
  • Understanding non-TRU subtypes is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To elucidate the molecular characteristics of major non-TRU-type lung adenocarcinoma subtypes.
  • To investigate the role of trefoil factor-1 (TFF-1) in non-TRU lung adenocarcinomas.
  • To assess TFF-1 as a potential biomarker and therapeutic target.

Main Methods:

  • Analyzed 19 lung adenocarcinoma cell lines (11 TRU, 8 non-TRU).
  • Performed immunohistochemical analysis of TFF-1 in 238 primary lung adenocarcinomas.
  • Correlated TFF-1 expression with other markers (HNF4-α, MUC5AC, TTF-1/NKX2-1) and mutations (EGFR, ALK, KRAS).
  • Investigated TFF-1's effect on cell proliferation, colony formation, and apoptosis via knockdown experiments.

Main Results:

  • TFF-1 was strongly expressed in non-TRU-type cell lines and detected in 13% of primary lung adenocarcinomas.
  • TFF-1 expression was frequent in mucinous, enteric, and colloid subtypes, inversely correlated with TTF-1/NKX2-1, and correlated with HNF4-α and MUC5AC.
  • TFF-1-positive cases showed high KRAS mutation frequency, lacked EGFR/ALK mutations, correlated with tumor spread, and indicated poor prognosis in advanced stages.
  • TFF-1 knockdown inhibited proliferation and colony formation, and induced apoptosis in a TFF-1-high, KRAS-mutated cell line.

Conclusions:

  • TFF-1 is characteristically expressed in non-TRU-type lung adenocarcinomas with gastrointestinal features.
  • TFF-1 serves as a potential biomarker for KRAS-mutated lung adenocarcinomas and predicts poor prognosis.
  • TFF-1 represents a potential molecular target for non-TRU-type lung adenocarcinomas.

Related Concept Videos

General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.6K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.3K